申请人:NIPPON ZOKI PHARMACEUTICAL CO., LTD.
公开号:EP0994113A2
公开(公告)日:2000-04-19
The invention provides 7-amino-1-phenylpyrido[2,3-d]pyrimidine-2,4-dione derivatives of the formula (I) or a pharmaceutically acceptable salt or hydrate thereof;
wherein
R1 is hydrogen, lower alkenyl, phenyl or optionally substituted lower alkyl which is optionally substituted with a substituent selected from oxo; lower alkoxy; phenyl which is optionally substituted with one or more lower alkyl, lower alkoxy, carboxyl, lower alkoxycarbonyl, mercapto, halogen, trifluoromethyl and/or nitro; naphthyl; furyl; isoxazolyl which is optionally substituted with one or more lower alkyl; pyridyl which is optionally substituted with one or more lower alkyl and/or halogen; thienyl which is optionally substituted with halogen; and 1,3-dioxolanyl; and
R2, R3 and R4 each independently is hydrogen, halogen, lower alkoxy, benzyloxy, carboxyl or lower alkoxycarbonyl,
which is useful for a therapeutic agent for bronchial asthma by exhibiting excellent bronchial dilating action as well as high safety and a favorable behavior in vivo.
本发明提供了式 (I) 的 7-氨基-1-苯基吡啶并[2,3-d]嘧啶-2,4-二酮衍生物或其药学上可接受的盐或水合物;
其中
R1 是氢、低级烯基、苯基或任选被选自以下取代基取代的低级烷基:氧代;低级烷氧基;任选被一个或多个低级烷基、低级烷氧基、羧基、低级烷氧羰基、巯基、卤素、三氟甲基和/或硝基取代的苯基;萘基;呋喃基;任选被一个或多个低级烷基取代的异噁唑基;任选被一个或多个低级烷基和/或卤素取代的吡啶基;任选被卤素取代的噻吩基;以及 1,3-二氧戊环基;以及
R2、R3 和 R4 各自独立地为氢、卤素、低级烷氧基、苄氧基、羧基或低级烷氧羰基、
该化合物具有优异的支气管扩张作用,安全性高,在体内表现良好,可作为支气管哮喘的治疗剂。